Abstract
ACE inhibitors have become an essential component in the treatment of heart failure. But is low-dose ACE inhibitor therapy as effective as high-dose ACE inhibitor therapy in this indication? This question was addressed at the 47th Annual Scientific Sessions of the American College of Cardiology [ Atlanta, US; March 1998 ], where the results of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial were presented.
Rights and permissions
About this article
Cite this article
Keating, G. Low-dose lisinopril inadequate in heart failure. Inpharma Wkly. 1134, 13–14 (1998). https://doi.org/10.2165/00128413-199811340-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811340-00021